Advanced search
Publication Cover
Journal of Inflammation Research Volume 16, 2023 - Issue
Submit an article Journal homepage
235
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Investigation of the Underlying Mechanism of Sclerosteosis Expression in Muscle Tissue in Multiple Myeloma with Sarcopenia

Jie Ren1 Department of Orthopaedics, Beijing Chao-yang Hospital, Beijing, 100020, People’s Republic of China
,
Jingzhou Wang2 Department of Orthopaedics, Beijing Daxing District People’s Hospital, Beijing, 102600, People’s Republic of China
,
Xingchen Yao1 Department of Orthopaedics, Beijing Chao-yang Hospital, Beijing, 100020, People’s Republic of China
,
Yue Wu1 Department of Orthopaedics, Beijing Chao-yang Hospital, Beijing, 100020, People’s Republic of China
,
Ming Shi1 Department of Orthopaedics, Beijing Chao-yang Hospital, Beijing, 100020, People’s Republic of China
,
Xiangjun Shi3 Department of Hematology, Beijing Chao-yang Hospital, Beijing, 100020, People’s Republic of China
&
Xinru Du1 Department of Orthopaedics, Beijing Chao-yang Hospital, Beijing, 100020, People’s Republic of ChinaCorrespondence[email protected]
 show all
Pages 563-578 | Received 10 Oct 2022, Accepted 16 Jan 2023, Published online: 11 Feb 2023

References

  • Rajkumar SV, Dimopoulos MA, Palumbo A, et al. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014;15:e538–e548. doi:10.1016/S1470-2045(14)70442-5
  • Songpatanasilp T, Sritara C, Kittisomprayoonkul W. Sarcopenia Consensus. Chin J Osteopo Bone Mineral Salt Dis. 2016;3:215–227.
  • Harimoto N, Shirabe K, Ikegami Y-IY, et al. Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma. Br J Surg. 2013;100(11):1523–1530. doi:10.1002/bjs.9258
  • Cruz-Jentoft AJ, Sayer AA. Sarcopenia. Lancet. 2019;393(10191):2636–2646. doi:10.1016/S0140-6736(19)31138-9
  • Tarantino U, Baldi J, Celi M, et al. Osteoporosis and sarcopenia: the connections. Aging Clin Exp Res. 2013;25(Suppl 1):S93–S95. PMID: 24046056. doi:10.1007/s40520-013-0097-7
  • Reiss J, Iglseder B, Alzner R, et al. Sarcopenia and osteoporosis are interrelated in geriatric inpatients. Z Gerontol Geriatr. 2019;52(7):688–693. PMID: 31049683; PMCID: PMC6817738. doi:10.1007/s00391-019-01553-z
  • Rier HN, Jager A, Meinardi MC, et al. Severe sarcopenia might be associated with a decline of physical Independence in older patients undergoing chemotherapeutic treatment. Support Care Cancer. 2018;26(6):1781–1789. doi:10.1007/s00520-017-4018-8
  • GuoBin L, Zhang L, Wang D, et al. Muscle-bone crosstalk and potential therapies for sarco-osteoporosis. J Cell Biochem. 2019;120(9):14262–14273. doi:10.1002/jcb.28946
  • Sebastian A, Loots GG. Genetics of Sost/SOST in sclerosteosis and van Buchem disease animal models. Metabolism. 2018;80:38–47. PMID: 29080811. doi:10.1016/j.metabol.2017.10.005
  • Balemans W, Ebeling M, Patel N, et al. Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST). Hum Mol Genet. 2001;10(5):537–543. PMID: 11181578. doi:10.1093/hmg/10.5.537
  • Sutherland MK, Geoghegan JC, Yu C, Winkler DG, Latham JA. Unique regulation of SOST, the sclerosteosis gene, by BMPs and steroid hormones in human osteoblasts. Bone. 2004;35(2):448–454. PMID: 15268896. doi:10.1016/j.bone.2004.04.019
  • Lintern KB, Sonia G, Alison R, et al. Characterization of wise protein and its molecular mechanism to interact with both Wnt and BMP signals. J Biol Chemis. 2009;284(34):23159–23168. doi:10.1074/jbc.M109.025478
  • Cooper AB, Slack R, Fogelman D, et al. Characterization of anthropometric changes that occur during neoadjuvant therapy for potentially resectable pancreatic cancer. Ann Surg Oncol. 2015;22(7):2416–2423. doi:10.1245/s10434-014-4285-2
  • Daly LE, Ní Bhuachalla ÉB, Power DG, et al. Loss of skeletal muscle during systemic chemotherapy is prognostic of poor survival in patients with foregut cancer. J Cachexia Sarcopenia Muscle. 2018;9(2):315–325. doi:10.1002/jcsm.12267
  • Adams SC, Segal RJ, McKenzie DC, et al. Impact of resistance and aerobic exercise on sarcopenia and dynapenia in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial. Breast Cancer Res Treat. 2016;158(3):497–507. doi:10.1007/s10549-016-3900-2
  • Van Bezooijen RL, Roelen BA, Visser A, et al. Sclerostin is an osteOCtrexpressed negative regulator of bone formation, but not a classical BMP antagonist. J Exp Med. 2004;15(1996):805–814. doi:10.1084/jem.20031454
  • Honma M, Ikebuchi Y, Kariya Y, et al. RANKL subcellular trafficking and regulatory mechanisms is osteocytes. J Bone Miner Res. 2013;28(9):1936–1949. doi:10.1002/jbmr.1941
  • Kramer I, Halleux C, Keller H, et al. Osteocyte Wnt/β-catenin signaling is required for normal bone homeostasis. Mol Cell Biol. 2010;30(12):3071–3085. doi:10.1128/MCB.01428-09
  • Jilka RL, Weinstein RS, Bellido T, et al. Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone. J Clin Invest. 1999;104(4):439–446. doi:10.1172/JCI6610
  • Arron JR, Choi Y. Bone versus immune system. Nature. 2000;408(6812):535–536. doi:10.1038/35046196
  • Russell RG. Bisphosphonates: from bench to bedside. Ann N Y Acad Sci. 2006;1068:367–401. doi:10.1196/annals.1346.041
  • Gnoni A, Brunetti O, Longo V, et al. Immune system and bone microenvironment: rationale for targeted cancer therapies. Oncotarget. 2020;11(4):480–487. doi:10.18632/oncotarget.27439

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.